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ABSTRACT
Prokaryotic toxin–antitoxin (TA) modules are highly
abundant and are involved in stress response and
drug tolerance. The most common type II TA mod-
ules consist of two interacting proteins. The type
II toxins are diverse enzymes targeting various es-
sential intracellular targets. The antitoxin binds to
cognate toxin and inhibits its function. Recently, TA
modules whose toxins are GNAT-family acetyltrans-
ferases were described. For two such systems, the
target of acetylation was shown to be aminoacyl-
tRNA: the TacT toxin targets aminoacylated elonga-
tor tRNAs, while AtaT targets the amino acid moi-
ety of initiating tRNAMet. We show that the itaRT
gene pair from Escherichia coli encodes a TA mod-
ule with acetyltransferase toxin ItaT that specifically
and exclusively acetylates Ile-tRNAIle thereby block-
ing translation and inhibiting cell growth. ItaT forms
a tight complex with the ItaR antitoxin, which re-
presses the transcription of itaRT operon. A compre-
hensive bioinformatics survey of GNAT acetyltrans-
ferases reveals that enzymes encoded by validated
or putative TA modules are common and form a dis-
tinct branch of the GNAT family tree. We speculate
that further functional analysis of such TA modules
will result in identification of enzymes capable of
specifically targeting many, perhaps all, aminoacyl
tRNAs.
INTRODUCTION
Toxin–antitoxin (TA) genes pairs are highly abundant in
bacterial and archaeal genomes (1,2). A TA pair consists
of proteinaceous toxin and a cognate antitoxin, which can
be either an RNA or a protein (3). Based on the nature
of antitoxin and the way it counteracts the action of cog-
nate toxin, TA systems are classified into six types (3), of
which the type II systems are so far the most extensively
studied. Type II antitoxins are proteins which forms a tight
complex with their cognate toxins, thereby blocking toxin
activity. It is generally accepted that antitoxins are less sta-
ble than toxins, especially under stress conditions. Degra-
dation of antitoxin by cellular proteases releases the active
toxin (4). The biological function of TA modules is not al-
ways clear. Substantial experimental evidence exists for par-
ticipation of some toxins in plasmid and unstable genomic
loci maintenance (5), where they act as selfish ‘addiction’
modules. Toxin activation can also benefit the host lead-
ing, for example, to the suicide of cells infected by bacte-
riophage (abortive infection), which limits the spread of the
virus in a clonal population (6). Some data also point to-
wards the importance of toxin–antitoxin modules for viru-
lence and persistence/antibiotic tolerance (7), although the
actual mechanisms are subject of debate and ongoing re-
search.
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Figure 1. Expression of itaT inhibits cell growth by impairing protein syn-
thesis. (A) Growth on LB agar plates ofE. coliMG1655 strain transformed
with pBAD33 control vector (pBAD) or the same plasmid expressing the
itaRT module, itaT or itaT* (itaT-Y150A mutant). Cells were grown un-
der non-inducing (0.2% glucose) and inducing (20 mM arabinose) con-
ditions as indicated. (B) Pulse-labeling of E. coli MG1655 cells harbor-
ing pBAD33-itaT plasmid grown on minimal medium supplemented with
arabinose and one of the radiolabeled precursors: [3H]-thymidine (THY),
[3H]-uridine (URI) or [35S]-methionine (MET). Incorporation of the ra-
dioactivity into DNA, RNA, and protein is normalized to OD450 in each
sample at 0, 5, 10 and 45 min of induction. The graph shows the percent-
age of normalized incorporation relative to that before the induction. Er-
ror bars in (B) and (D) indicate standard deviation from three independent
experiments (see Materials and Methods for details).
Type II toxins target diverse essential biosynthetic path-
ways of bacteria such as cell wall synthesis, DNA repli-
cation and protein translation (8). Interference with nor-
mal cell metabolism can be achieved either through physi-
cal destruction or reversible modification of targets. Among
the validated targets of type II toxins are DNA gy-
rase, aminoacyl-tRNA synthetases, EF-TUand site-specific
cleavage of free or ribosome-bound mRNA, tRNA, or
rRNA (9). This list is by no means complete, as bioinfor-
matics surveys continue to identify novel, putative TAmod-
ules, most of which remain uncharacterized (10,11). Re-
cently, a new class of type II toxins belonging to GCN5-
related (GNAT) superfamily of N-acetyltransferases was
characterized. Toxins from Salmonella Typhimurium were
shown to inhibit translation through acetylation of mul-
tiple elongator aminoacyl-tRNAs (12,13). Another trans-
lational inhibitor, the AtaT toxin from Escherichia coli
O157:H7, was shown to specifically acetylate the amino
group of initiator Met-tRNAfMet preventing its interaction
with IF2·GTP (14,15). Toxicity of several other GNAT type
II toxins has been demonstrated although their actual tar-
gets remain unknown (12,14,16–20).
In this work, we describe a new itaRT type II toxin–
antitoxin module from E. coli HS. The ItaT toxin forms
a tight complex with the ItaR antitoxin, and this com-
plex represses transcription of the itaRT operon. ItaT is a
Gcn5 family acetyltransferase protein. It inhibits protein
synthesis by acetylation of charged tRNA. Unlike previ-
ously described tRNA-acetylating toxin AtaT, ItaT specif-
ically acetylates both isoaccepting elongator Ile-tRNAIles.
Our results expand the repertoire of targets of type II acetyl-
transferase toxins. Computational analysis indicates that
toxins of this type are both numerous and diverse, suggest-
ing that additional specificities may be found in nature.
MATERIALS AND METHODS
Plasmid construction
Escherichia coli DH5 was used for cloning. All primers
were synthesized by Evrogen (Russia); their sequences
are listed in Supplemental Table S1. PCR-amplification
was carried out using Phusion DNA polymerase (Thermo
Fisher Scientific, USA). To construct plasmids for in vivo
phenotypic assays, the itaRT module, itaR and itaT genes
were PCR-amplified from E. coli HS genomic DNA with
primers ItaR F and ItaT R, ItaR F and ItaR R, ItaT F
and ItaT R, respectively. The PCR products were digested
with KpnI and HindIII and inserted under the same sites
into a pBAD33 vector containing an arabinose-inducible
promoter, creating plasmids pBAD-itaRT, pBAD-itaR,
pBAD-itaT. The itaT-Y150A mutant (itaT*) was obtained
by site-directed mutagenesis using overlap–extension PCR
(21) on an itaT DNA template with a combination of
ItaTY F and ItaTY R primers together with universal
pBAD-Forward and pBAD-Reverse primers. The mutant
itaRT*modulewas obtained similarly using the itaRTmod-
ule as a template. The PCR products were digested with
KpnI andHindIII and inserted into pBAD33, creating plas-
mids pBAD-itaRT, pBAD-itaR, pBAD-itaT* and pBAD-
itaRT*.
To construct a plasmid for tandem affinity purifica-
tion of ItaRT complex, a two-step procedure was used.
First, a Strep-tag was introduced into a pET22b vector
(Novagen-Millipore, USA). For this, the phosphorylated
self-complementary oligonucleotides ST U and ST D were
annealed and inserted into pET22b digested with NdeI
and BamHI, resulting in pET22-strep-his vector. Then, the
itaRTmodule was PCR-amplified with Ita FB and Ita RX
primers and inserted into pET22-strep-his between BamHI
and XhoI, resulting in pET22-strep-itaRT-his. To construct
a plasmid for ItaT purification, the itaRT module was first
PCR-amplified using Ita FB and Ita RXS primer. Then,
the PCR product was digested with BamHI and XhoI and
ligated into pETDuet-1 vector (Novagen-Millipore, USA)
cut with the same enzymes to create pET-his-itaRT plas-
mid.
To construct a transcriptional fusion reporter plasmid for
analysis of the regulatory function of ItaR-ItaT complex,
the 5′-UTR region of itaRT module spanning from posi-
tion−183 to−11 relative to the expected transcription start
site containing putative promoter was amplified with ItaPF
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Figure 2. ItaT overproduction leads to cessation of cell growth and affectsmembrane permability. Time-lapsemicroscopy ofE. coliMG1655 cells harboring
pBAD33 control plasmid (left two columns) or pBAD33-itaT plasmid (right two columns) growing on LB-agarose blocks in the presence of 10 mM
arabinose and propidium iodide. Transmitted light and fluorescent microscopy images are shown.
and ItaPRprimers. The resulting PCRproductwas digested
with EcoRI and EcoRV and inserted into pFD51-galK (22)
at the same sites to create pFD-PitaRT-galK.
Rates of protein, DNA and RNA synthesis
Escherichia coli MG1655 cells harboring pBAD33-itaT
were grown at 37◦C in 50 ml of M9 minimal media con-
taining a mixture of 19 amino acids without methionine
to OD450 = 0.4. Cells were then divided into two 25 ml-
cultures and grown at 37◦C with aeration in the absence
or presence of 20 mM arabinose. 500 l-aliquots before
the induction and 5, 10 and 45 min after induction were
taken and mixed with 25 l of solution containing 1 Ci
of L-[35S]-methionine (1135 Ci/mmol), 2.5 Ci [methyl-
3H]-thymidine (6.7 Ci/mmol), or 2.5 Ci [5-3H]-uridine
(20 Ci/mmol) (Perkin-Elmer, USA) supplemented with 10
ng/ml of unlabeled L-methionine, thymidine or uridine, re-
spectively. The pulse-labeling was carried out for 2 min at
37◦C on a shaker, and incorporation of radioactive isotopes
was halted by the addition of 100 l of 40% TCA. Sam-
ples were transferred onto glass microfiber filters (What-
man, USA), filters were successively washed with 2 ml of
10% TCA and 2 ml of ice-cold ethanol. The radioactivity
of insoluble material trapped on filters was measured in a
liquid scintillation counter LS60001C (Beckman Coulter,
USA). Incorporation of the radioactivity into DNA, RNA
and protein is normalized to OD450 in each sample at 0, 5,
10 and 45 min of induction. The 100% incorporation cor-
responds to the value of relative radioactivity observed in
samples before the induction (at 0 min).
Regulation of itaRT expression assay
Escherichia coli HB101 cells harboring promoterless re-
porter pFD51-galK or transcriptional fusion reporter
pFD-PitaRT-galK were co-transformed with pBAD-itaR,
pBAD-itaT, pBAD-itaRT, or an empty vector pBAD33.
Cells were grown in LBmedia supplementedwith ampicillin
(50 g/ml), chloramphenicol (35 g/ml) and 10 mM arabi-
nose until OD600 = 0.6. Cells were harvested by centrifuga-
tion, and total RNA was extracted using acid-phenol RNA
extraction method. One g of total RNA was treated with
DNase and reverse-transcribed using Maxima First Strand
cDNA Synthesis Kit (Thermo Fisher Scientific, USA) with
random hexamer primer. The subsequent qPCR analysis of
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Figure 3. ItaR and ItaT form a stable complex which represses transcrip-
tion from itaRT promoter independent from the ItaT acetylating activity.
(A) Tandem affinity purification of 6xHis-tagged ItaR co-expressed with
Strep-tagged ItaT (left panel, lanes 1–7) or with Strep-tagged ItaT* (right
panel, lanes 8–14). Samples separated on Talon Co2+-chelating (lanes 1–4
and 8–11) agarose and Strep-Tactin agarose (lanes 5–7 and 12–14) were
analyzed by SDS-PAGE followed by Coomassie staining. Lanes 1–4 and
8–11 represent the initial cell lysates, unboundmaterial, wash fractions and
the eluates from Talon resin, respectively. Lanes 5–7 and 12–13 represent
the unbound material, wash fractions and the eluates from Strep-Tactin
resin, respectively. LaneM shows the molecular weight markers. Black and
red arrowheads on the right indicate positions of the ItaT and ItaR pro-
tein bands, respectively. (B) RT-qPCR analysis of the relative expression
of the galK transcript in E. coli. Transcriptional fusion reporter plasmid
pFD-PitaRT-galK carrying galK under a putative PitaRT promoter or in a
promoterless construct (pFD-galK) were co-transformed with an empty
vector pBAD33, or plasmids expressing ItaR (pBAD-ItaR), co-expressing
ItaR and ItaT (pBAD-ItaRT), or ItaRT* (pBAD-ItaRT*). The bars show
the relative galK expression level (in log scale) normalized to the level of bla
transcript expressed from the same plasmid. Error bars indicate standard
deviation obtained from three independent measurements.
bla and galK cDNAs was carried out using Maxima SYBR
Green/ROX qPCRMaster Mix (Thermo Fisher Scientific)
and respective pairs of primers: Amp F with Amp R or
Gal F withGal R. Absolute quantification (standard curve
method) was applied to calculate the expression levels. The
standard curves for bla and galKDNAswere obtained using
serial dilutions of the pFD51 plasmid. The resulting galK
expression level was normalized to the expression level of
bla gene.
Microscopy
Escherichia coli MG1655 cells harboring pBAD33 or
pBAD-itaT were grown in LB to an OD600 = 0.5. An
aliquot of the cell culture was transferred to LB-1.5%
agarose block supplemented with 0.2% glucose or 10 mM
arabinose, and 20 nM propidium iodide (Sigma-Aldrich,
USA) and placed into amicroscope chamber of Nikon Ti-E
invertedmicroscope. Two agarose blocks can fit into onemi-
croscope chamber enabling simultaneousmonitoring of cell
growth of induced and uninduced cultures (23). To observe
cell recovery after brief induction of ItaT expression, E. coli
MG1655 cells carrying pBAD-itaTwere grown to anOD600
= 0.5, induced by the addition of 10 mM arabinose, and
allowed to grow for additional 30 min at 37◦C. Cells were
harvested by centrifugation, resuspended in fresh LB con-
taining 0.2% glucose and 20 nM propidium iodide, trans-
ferred to LB–1.5% agarose and placed into the microscope
chamber for time-lapse observations. The microscope was
equipped with Andor’s Zyla 4.2 sCMOS camera, Semrock
mCherry-40LP filter set for propidium iodide fluorescence
detection and custom-made incubation system to maintain
cells at 37◦C. Image analyses were performed using Fiji-
ImageJ software package (24).
Protein expression and purification
ItaRT tandem affinity chromatography. Escherichia coli
BL21(DE3) cells carrying pET22-strep-itaRT-his plasmid
were grown to OD600 of ∼0.6 in 20 ml of LB medium
containing ampicillin (50 g/ml). Protein expression was
induced with 1 mM isopropyl--D-thiogalactopyranoside
(IPTG), followed by growth at 18◦C for 16 h. Cells were
harvested by centrifugation, washed with BW buffer (20
mM Tris–HCl, pH 8.0; 300 mM NaCl) and resuspended
in 2 ml of BW buffer supplemented with 0.2 mM phenyl-
methanesulfonyl fluoride (PMSF), 1mg/ml lysozyme, and 1
mM -mercaptoethanol. The cells were lysed by sonication,
and the debris was removed by centrifugation. The clarified
cell lysate was mixed with 100 l of Talon CellThru Co2+-
chelating resin (Takara-Clontech, USA) pre-equilibrated
with BW buffer and incubated with gentle rotation at 4◦C
for 2 h. The resin waswashedwith BWbuffer, and the ItaRT
complex was eluted with 1 ml of EB buffer (50 mM Tris–
HCl, pH 8.0; 0.5 M imidazole, 300 mM NaCl). The eluted
material was combined with 100 l of Strep-Tactin Super-
flow Plus resin (Qiagen, USA) and incubated with gentle
rotation at 4◦C for 4 h. The resin was washed with BW
buffer and eluted with 1 ml of BW buffer containing 2.5
mMdesthiobiotin (Sigma-Aldrich, USA). Protein fractions
were analyzed using Laemmli 12% SDS-PAGE. The gel was
stained with EZblue protein stain (Sigma-Aldrich, USA)
according to the manufacturer’s protocol.
ItaT expression and purification. Escherichia coli
BL21(DE3) cells harboring pET-his-itaRT were grown in
LB media to an OD600 of 0.8, and induced with 1 mM
IPTG for 16 h at 18◦C. Cells were harvested by centrifuga-
tion and lysed by sonication in 50 ml of lysis buffer (50 mM
Tris–HCl pH 7.5, 500 mM NaCl, 0.5 mM PMSF). The
lysate clarified by centrifugation was incubated with 1 ml
of Talon CellThru Co2+-chelating resin (Takara-Clontech)
with agitation for 3 h at 4◦C. The resin was washed with
100 ml of wash buffer (50 mM Tris–HCl, pH 7.5; 500
mM NaCl, 10 mM imidazole) and the ItaRT complex
anchored at the resin by 6xHis-tagged ItaR was treated
with 10 ml of denaturing buffer (50 mM Tris–HCl pH 7.5,
500 mM NaCl, 5 M guanidine-HCl). The denatured ItaT
dissociated from the ItaRT complex was separated from
the resin and refolded by dialysis at 4◦C for 16 h in 2 L of
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Figure 4. ItaT inhibits translation by acetylation of tRNA. (A) Activity of firefly luciferase synthesized in in vitro coupled transcription-translation PUR-
Express system in the absence or presence of ItaT, acetyl-CoA (AcCoA) or both. The graph shows the relative luminescence of samples obtained from three
independent experiments expressed in arbitrary units, AU. The error bars represent standard deviation. (B) SDS-PAGE analysis of DHFR produced in the
transcription-translation reaction described in (A). Reactions were supplemented with [14C] acetyl-CoA and carried out in the absence (left) or presence of
ItaT (right). Reaction products were visualized with Coomassie blue staining. The position of the DHFR protein band is indicated by the red arrowhead
on the left. Lane M shows the molecular weight markers. (C) Analysis of tRNAs extracted from the samples shown in (B) by acid-urea PAGE followed by
methylene blue staining (top panel) and autoradiography (lower panel). The position of tRNAs on the gel is indicated by the black arrowhead on the right.
dialysis buffer (25 mM Tris–HCl, pH 7.5; 25 mM NaCl, 1
mM DTT, 5% glycerol). Ca. 50% of ItaT remained soluble
after dialysis, the rest precipitated and was discarded. The
concentration of soluble ItaT was determined by Bradford
method. ItaT was flash-frozen and stored at −80◦C.
Asp-RS and Ile-RS purification. Escherichia coli JW0024
and JW1855 strains from ASKA collection (25) were used
for Ile-RS and Asp-RS purification, respectively. Cells were
grown in 250 ml of LB medium containing chlorampheni-
col (34 g/ml) at 37 ◦C to OD600 = 0.6 followed by 2 h-
induction with 1 mM IPTG. The induced cells were col-
lected by centrifugation, sonicated in 5 ml of BW buffer
supplemented with 0.2 mM PMSF, 1 mg/ml lysozyme
and 1 mM -mercaptoethanol. The His-tagged Ile-RS and
Asp-RS were purified using HiTrap Co2+-chelating HP
Sepharose column (GE Healthcare). Proteins were eluted
with EB buffer and applied on MonoQ 5/50 GL (GE
Healthcare) column pre-equilibrated with Buffer A (20mM
HEPES pH 6.8, 50 mM NaCl) and eluted using the linear
gradient of NaCl (from 50 to 500 mM) in the same buffer.
Protein concentrationwas determined byBradfordmethod.
In vitro translation and toeprinting assays
The in vitro coupled transcription-translation reactions
were carried out by PURExpress kit (NEB, USA) us-
ing DNA templates encoding the dihydrofolate reductase
(DHFR) (NEB, USA) or the firefly luciferase (Promega,
USA). Before template addition, translation reactions were
incubated for 10 min at 37◦C in the presence of 0.2 mM of
cold acetyl coenzyme A (AcCoA) or radiolabeled [acetyl-1-
14C]-AcCoA (0.2Ci, 60mCi/mmol), Perkin Elmer, USA),
with and without 2 M ItaT. The enzymatic activity of in
vitro synthesized luciferase was measured using the Steady-
Glo Luciferase Assay System (Promega, USA). The prod-
ucts of DHFR in vitro translation reactions were analyzed
by SDS-PAGE or by 12% denaturing acid-urea PAGE fol-
lowed by autoradiography (12).
The DNA templates for in vitro translation of the wild-
type and isoleucine-containing yncJmutants were prepared
by PCR of E. coli MG1655 genomic DNA using a re-
verse primer yncJ NV1 R and one of the forward primers:
yncJ WT F, yncJ atc F or yncJ ata F. The PCR products
were converted to mRNA using T7Megascript in vitro tran-
scription kit (Ambion, USA). In vitro translation reactions
were carried out as described above except that the reaction
mixture was supplemented with 0.5 Ci of L-[14C]-valine
(Perkin Elmer, USA). The reaction products were analyzed
by SDS–PAGE followed by autoradiography.
The toeprinting assay was carried out using Rst1 and
Rst2 mRNA as templates as described in (26), except that
reactions were preincubated for 10 min with 0.4 mM Ac-
CoA with or without the addition of 2 M ItaT.
In vitro aminoacylation, acetylation and RNaseT1 treatment
The aminoacylation of the tRNAsIle(GAU) and tRNAAsp
(Subriden RNA, Rollingbay, WA, USA) was performed in
20 l of reaction buffer (9 mMMg-acetate, 5 mMKH2PO4
(pH 7.3), 95 mM K-glutamate, 5 mM NH4Cl, 0.5 mM
CaCl2, 1 mM spermidine, 8 mM putrescine, 1 mM DTT)
supplemented with 5 mM ATP, 0.5 mM of aspartate or
isoleucine, 1 l of corresponding aminoacyl tRNA syn-
thetase and 3 g of the tRNA. The reaction mixture was
incubated at 37◦C for 30 min followed by the addition of
0.4mMAcCoA and 2MItaTwith subsequent incubation
at 37◦C for 10 min. 3l of the reaction mixture was treated
with 1URNase T1 (NEB, USA) for 30 min. For acetylation
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Figure 5. ItaT blocks translation on Ile codons in the presence of acetyl-
CoA. (A) mRNA toeprint assay of ItaT specificity. Two DNA templates
coding for 20- and 21-amino acid-long peptides (left and right panels, re-
spectively) each containing codons for all 20 amino acids were used in
in vitro transcription-translation assay (same as in Figure 3B) followed
by reverse-transcription reaction. Samples were separated by denaturing
urea-PAGE along with the DNA-sequencing markers (four leftmost lanes
in each gel) and visualized by autoradiography. Specific bands that are
present in the reactions containing both ItaT and acetyl-CoA but absent
in the control samples correspond to codon-specific translation arrest. The
peptide and corresponding mRNA sequences are shown on the left side
of each panel. Positions on mRNA where reverse transcription is termi-
nated due to the presence of stalled ribosome (toeprints) are indicated with
red arrowheads. Codons located in the A-site of the stalled ribosome are
marked by open red boxes. Note that owing to the large size of the ribo-
some, the reverse transcriptase stops at nucleotide +13 relative to the first
base of mRNA codon located in the A site (38). (B) In vitro translation
assay of the wild-type yncJ mRNA (w.t.) and its variants carrying alter-
native isoleucine codons (AUA and AUC). Reactions were supplemented
with acetyl-CoA and [14C]-valine and carried out in the presence or ab-
sence of ItaT, as indicated above the lanes. Radiolabeled reaction prod-
ucts were separated by SDS-PAGE and visualized by autoradiography and
Phosphorimager. The position of bands, corresponding to the full-length
YncJ is indicated by a blue arrowhead.
site identification charged acetylated tRNAIle was treated
with 1 g/ml RNase A in water at RT for 5 min.
Mass spectrometry
MALDI-TOF MS analysis was performed on UltrafleXe-
tremeMALDI-TOF/TOFmass spectrometer (Bruker Dal-
tonik, Germany) equipped with Nd laser. Samples for anal-
ysis were prepared as described (27). TheMH+of ItaR pro-
tein was measured in a linear mode; the accuracy of average
mass peakmeasurement was within 1Da. TheMH+molec-
ular ions of RNase T1-treated tRNAs were measured in re-
flectormode; the accuracy ofmonoisotopicmass peakmea-
surement was within 30 ppm. Fragmentation spectra were
obtained in LIFTmode, the accuracy of daughter ionsmea-
surement was within 1 Da range. Mass-spectra were pro-
cessed using FlexAnalysis 3.2 software (Bruker Daltonik,
Germany) and analyzed manually.
GNAT sequence analysis
A full set of 4961 completely sequenced prokaryotic
genomes was downloaded from the NCBI GenBank
database (28) in March 2016 and annotated using PSI-
BLAST (29)withCDDprofiles (30). Proteins,matching one
of the 16 GNAT profiles in CDD as well as those, not anno-
tated identified with CDD, but identified using PSI-BLAST
searches with knownGNAT representatives as queries were
filtered to remove multidomain proteins, resulting in the set
of 96 453 GNAT sequences. The same procedure initiated
with 46 antitoxin profiles and a set of known antitoxins pro-
duced a list of 98 182 predicted antitoxin sequences. Using
this information all GNAT genes were classified into two
groups: 2286 GNATs that are adjacent to antitoxins in the
genomes and the remaining 94 167 GNATs.
Both sets of GNAT sequences were clustered using
UCLUST (31) with the similarity threshold of 0.9; one rep-
resentative of each cluster was selected for the further anal-
ysis (37,902 distinct sequences). The set of representatives
was clustered using UCLUST with the similarity threshold
of 0.5; sequences within a cluster were aligned using MUS-
CLE (32); singletons were added to the set of clusters as
pseudo-alignments.
GNAT sequence clusters were further classified as
follows: PSI-BLAST searches with GNAT alignments
used as PSSMs were performed against the database,
consisting of cluster consensus sequences. PSI-BLAST
scores were converted into distances using the dA,B = -
ln(sA,B/min(sA,A,sB,B)) formula, where dA,B is the distance
between cluster A and B and sA,B is the PSI-BLAST
score for the comparison of these clusters. UPGMA tree
was constructed from the distance matrix and cut at dis-
tance 1 from the leaves, forming clusters of clusters (su-
perclusters). Superclusters, not containing any antitoxin-
associated GNATs, were excluded from further analysis, re-
sulting in the set of 24 454 sequences.
This set was further aligned using the following itera-
tive procedure. All cluster alignments (including pseudo-
alignments of singleton sequences) were compared to each
other using HHSEARCH (32); HHSEARCH similarity
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Figure 6. ItaT specifically acetylates charged tRNAIle.MALDI-TOFMS spectra of RNase T1-treated tRNAs. Acetylation activity of ItaTwas tested using
the tRNAIle (left panels) and control tRNAAsp (right panels). Uncharged tRNAs (top two panels) or charged tRNAs (bottom two panels) were analyzed
before and after treatment with ItaT in the presence of acetyl-CoA, as indicated on the left. For specific peak description, see text. Them/z values for peaks
corresponding to the 3′-terminal fragments of the uncharged or aminoacylated tRNAs are shown in blue. The m/z value of the peak corresponding to the
3′fragment of acetylated Ile-tRNAIle is shown in red. Insets show the zoomed-in view of the mass peaks of the unmodified and acetylated fragments of the
3′-isoleucyl- tRNAIle (5′-CCUACCA-3′-Ile).
scores were converted to distances as described above; UP-
GMA trees were reconstructed from the pairwise distance
matrices; tips of the UPGMA tree were used to guide pro-
gressive pairwise alignment of clusters using HHALIGN
(33).
After the final iteration, the resulting alignments were
filtered for positions containing over 50% of gaps and
used to reconstruct approximate maximum likelihood trees
using FastTree (34) (WAG evolutionary model, gamma-
distributed site rates). The trees were rooted using a variant
of the midpoint root procedure and combined into a single
tree according to the UPGMA tree from the last round of
the inter-cluster comparisons.
RESULTS
The itaT and itaR E. coli genes comprise a toxin–antitoxin
system
The Escherichia coli HS genome (locus tag EcHs A0501-
EcHs A0501) contains two partially overlapping genes,
itaR, which encodes an 11.4-kDa protein containing an
RHH DNA-binding domain characteristic of many type
II antitoxins, and a downstream gene itaT, whose prod-
uct is a 19.8-kDa GNAT family protein. The itaRT gene
pair or itaT alone were cloned into a plasmid vector under
control of an arabinose-inducible promoter.Escherichia coli
MG1655 cells co-expressing itaR and itaT grew normally in
the presence of arabinose. In contrast, the growth of cells
expressing itaT alone was severely impaired under induc-
ing conditions (Figure 1A), indicating that ItaT is toxic to
cells. To test which major cellular process was affected by
itaT expression the most, we performed metabolic pulse-
labeling analysis of induced cells. As can be seen from Fig-
ure 1B, the effect on [3H]-thymidine incorporation was min-
imal, [3H]-uridine incorporation was modestly (30%) af-
fected 10 min post-induction, while incorporation of [35S]-
methionine was affected strongly (80% inhibition) and the
effect was evident 5 minutes post-induction. The results
thus suggest that ItaT affects translation/protein synthesis.
To directly monitor cell fate upon itaT induction, we an-
alyzed cells by live microscopy. Consistent with observed
growth inhibition on agar plates (Figure 1A), the growth
rate of cells harboring pBAD-itaT plasmid on arabinose-
containing LB agarose blocks was dramatically lower than
on glucose-containing medium (Supplementary Figure S1).
Ninetyminutes post-induction, only a small fraction of bac-
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Figure 7. ItaT acetylates the 3′-terminal isoleucyl-adenosine in charged tRNAIle. TandemMS–MS fragmentation spectra of the 3′-fragment of uncharged
(top panel), Ile-charged (middle panel), and Ile-charged ItaT-acetylated (bottom panel) tRNAIle fragments. The identity of ribonucleotides deduced from
the spectra is indicated on top of each panel. The 3′-terminal isoleucyl-adenylate and N-acetyl-isoleucyl-adenylate fragments and their m/z values are
shown in red. For detailed description of peaks, see text.
teria managed to finish a single cycle of cell division, while
control cells transformed with an empty vector pBAD33 di-
vided several times during this period (Figure 2). No vis-
ible changes in the shape of the itaT-expressing cells 90
min post-induction were observed, and their membranes
appeared to remain intact. At longer post-induction times,
cells expressing itaT but not the control cells were stained
with propidium iodide (Figure 2), indicating that their
membrane became compromised. To test if cells can re-
cover from ItaT action, we induced them for 30 min and
then transferred onto glucose-containing agarose blocks
and observed them under the microscope. As can be seen
from Supplementary Figure S2, most cells eventually be-
came stained with propidium iodide and therefore were un-
able to recover. Yet, there was also a minor fraction of cells
that after∼100 min period of non-growth, started dividing,
implying the existence of a detoxification mechanism.
Although GNAT family proteins show little identity in
the primary structure, they possess a conserved fold (35).
Structural alignment of ItaT homology-based model with
the structures of Y145F KacT and Y148F TacT toxins
(PDB ID: 5XUN, 5FVJ respectively) suggested that Y150
of ItaT could serve as a general acid that protonates the
thiolate anion of CoA during the acetyl transfer reaction
(35,36). A plasmid expressing ItaT*, an ItaT mutant carry-
ingY150A substitution, was constructed. Cells overproduc-
ing ItaT* grew normally (Figure 1A), indicating that toxic-
ity of ItaT was abolished by the mutation.
The ItaRT complex is required for regulation of its own ex-
pression
Since the itaT toxicity was alleviated in the presence of itaR
(Figure 1A), we tested whether ItaT and ItaR interact with
each other. A plasmid co-expressing N-terminally Strep-
tagged ItaR and C-terminally 6xHis-tagged ItaT was con-
structed. Extract of induced cells harboring such a plas-
mid was subjected to tandem affinity chromatography. Ma-
terial from the Talon Co2+-chelating resin to which 6xHis-
tagged ItaT was expected to bind was subjected to the sec-
ond round of purification on Strep-Tactin agarose. As can
be seen from an SDS-PAGE presented in Figure 3A (lanes
1–7), the two proteins were eluted from this resin in appar-
ently stoichiometric amounts (lane 7). The ItaRT* complex
was also obtained (Figure 3A, lanes 8–14).
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Figure 8. Classification and evolution of GNAT sequences. (A) Position of the AtaT/TacT/ItaT (red) and X (magenta) groups among other GNAT se-
quences. (B) Approximate maximum likelihood subtree of the AtaT/TacT/ItaT group is schematically shown on the left. Previously identified acetyltrans-
ferase toxins (17) are indicated. (C) Approximate maximum likelihood subtree of the ItaT clade. Support values calculated by the FASTTREE program
are indicated for each branch.
The expression of Type II TA module genes is often con-
trolled by the antitoxin and the toxin–antitoxin complex.
Moreover, in the case of tacAT, which is related to itaRT,
it was shown that the TacT toxin acetylates the TacA anti-
toxin, which increases the affinity of the complex to tacAT
operon promoter (37). We tested whether ItaT can acety-
late its cognate antitoxin ItaR. To this end, we measured
the molecular mass of ItaR antitoxin from purified ItaRT
and ItaRT* complexes by MALDI-TOF mass spectrome-
try (Supplementary Figure S3). In both samples antitoxin
appeared as a single peak with an average [MH+] of 14512,
matching the expected mass of ItaR with intact N-terminal
affinity tag and removedN-terminal methionine residue. To
test if the putative acetylating activity of ItaT is required
for regulation of itaRT operon expression, we cloned the
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172 bp-long upstream region of the itaRT operon contain-
ing a putative promoter into the pFD51 plasmid carrying
promoterless galK gene (20). Cells harboring the resulting
pFD-PitaRT-galK fusion plasmid and compatible pBAD33
plasmids expressing itaR, itaRT or itaRT* were induced
with arabinose, total RNA was extracted, and levels of
galK transcripts were measured by RT-qPCR (Figure 3B).
Cells harboring pFD-PitaRT-galK transcription fusion plas-
mid and empty pBAD33 vector had ∼40-fold higher levels
of galK transcripts than cells carrying promoterless pFD51-
galK control. Expression of itaR in the presence of either
wild-type or mutant ItaT toxin decreased the amount of
galK transcripts almost to background level. In contrast,
expression of itaR alone had no effect. Thus, our data indi-
cate that the ItaRT complex negatively regulates the itaRT
expression, but this regulation is independent of the puta-
tive ItaT acetylating activity.
ItaT inhibits translation in vitro and acetylates tRNA
The ItaT action was next investigated in vitro. While the ad-
dition of recombinant ItaT or acetyl-CoA alone did not af-
fect the synthesis of luciferase in an in vitro transcription-
translation reaction, the simultaneous addition of ItaT and
acetyl-CoA led to∼200-fold decrease in luminescence (Fig-
ure 4A), in agreement with data obtained in vivo (Figure
1B).
To identify the target of ItaT, we performed in vitro trans-
lation of dihydrofolate reductase (DHFR) in PURExpress
system in the presence of [14C]-acetyl-CoA (Figure 4B). The
production of DHFR was inhibited in the presence of pu-
rified ItaT, as judged by the absence of an ∼18 kDa band
present in control reaction. Total RNA was next purified
from in vitro translation reactions, subjected to acid-urea
PAGE and radioactively labeled products were revealed
by autoradiography (Figure 4C). Previously, the same ap-
proach was used to demonstrate that TacT acetylates tRNA
(11). As can be seen, reaction containing ItaT and [14C]-
acetyl-CoA but not the control reaction lacking ItaT con-
tained radioactively labeled tRNA, suggesting that ItaT in-
hibits translation by means of tRNA acetylation.
ItaT prevents translation of isoleucine codons
To reveal a specific effect of ItaT on protein synthesis, a
toeprinting experiment was performed with mRNA con-
taining an engineered shortORFharboring codons for each
of the 20 amino acids (26). Stalling of a ribosome at a par-
ticular codon of the template manifests itself in the accu-
mulation of primer extension products that arise due to the
inability of reverse transcriptase to dislodge the ribosome
(38). In the absence of ribosome stalling, most primers are
elongated to the 5′ end of mRNA. As can be seen from
Figure 5A, left, a strong stalling site was observed in re-
actions containing ItaT and acetyl-CoA. Mapping of the
stall site indicates that it must have arisen due to ribosome
stalling at the isoleucine AUC codon in the A-site, which
is the fifth codon in the template used. To understand if
the toeprint induced by ItaT is position-specific or is deter-
mined by the nature of the codon, toeprinting experiment
was repeated with an alternative mRNA template where the
AUC codon was located at position 14. As can be seen from
Figure 5A, right, the position of ItaT-acetyl-CoA induced
toeprint was moved further downstream on this template
and corresponded to ribosome stalling at the Ile14 codon.
The results thus suggest that ItaT induces specific stalling
at isoleucine codons, rather than stalling at a particular dis-
tance from the translation start site.
In Bacteria, the isoleucine residue is encoded by three
codons: AUU, AUC, and AUA. Two of these codons,
AUU and AUC, are recognized by Ile-tRNA(GAU), while
rare AUA codon is decoded by minor Ile-tRNA(k2CAU)
(39,40). To further address the issue of ItaT specificity, we
made use of E. coli yncJ, a short ORF, which codes for
an 8.7 kDa protein of unknown function. The YncJ se-
quence lacks isoleucine residues, while the other 19 amino
acids are present. In vitro translation of the yncJ mRNA
was performed in the presence or the absence of acetyl-
CoA and ItaT. As can be seen from Figure 5B, ItaT had
no effect on the accumulation of wild-type YncJ. To deter-
mine if ItaT can inactivate both Ile-tRNA(k2CAU) and Ile-
tRNA(GAU), we created two versions of the yncJ gene har-
boring either the AUC codon or the AUA codon at position
2. In vitro translation of the mutant yncJ mRNAs in the
presence or the absence of acetyl-CoA and ItaT was next
performed (Figure 5B). The synthesis of both isoleucine-
containing YncJ variants was inhibited by ItaT and acetyl-
CoA. The result thus suggests that the aminoacyl part of
tRNA rather than tRNA itself is the major determinant of
ItaT specificity.
ItaT acetylates the aminoacyl-adenosine moiety of charged
tRNAIle
We next sought to map the ItaT acetylation site. tRNAIle
and control tRNAAsp were aminoacylated in vitro us-
ing cognate aminoacyl-tRNA synthetases. Both uncharged
and charged tRNAs were treated with ItaT in the pres-
ence of acetyl-CoA. The tRNAs were then treated with
RNase T1, which cleaves single-stranded RNA 3′ after
guanine residues, and the products were analyzed using
MALDI mass spectrometry. RNase T1 treatment results
in the production of an m/z = 2123.3 3′-terminal frag-
ment of Ile-tRNA(GAU), 5′-CCUACCA-3′, which is par-
tially converted to anm/z= 2236.3 mass-ion after aminoa-
cylation with isoleucine. In the case of tRNAAsp, the 3′-
terminal fragment 5′-CCA-3′ with m/z = 878 is converted
to an m/z = 993 mass-ion by aminoacylation with cognate
amino acid. Treatment of uncharged tRNAIle, tRNAAsp
or aminoacylated Asp-tRNAAsp with ItaT and acetyl-CoA
did not lead to alterations of their mass-spectra (Figure 6).
In contrast, charged Ile-tRNAIle incubation with ItaT and
acetyl-CoA resulted in the appearance of an additionalm/z
= 2278.4 mass-ion. The 42 Da shift (from 2236.3 to 2278.4)
is consistent with acetylation.
Tandem mass-spectrometry was next used to map the
position of the acetyl group in the Ile-tRNAIle. Compar-
ative analysis of fragmentation spectra of 2123.4, 2236.4
and 2278.4 mass-ions revealed the presence of an m/z =
363 peak matching the 3′-terminal riboadenosine charged
with Ile in the spectrum of ItaT-untreated reaction. No
such peak was observed in the spectrum of the ItaT-treated
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sample. Instead, an m/z = 405 mass-ion matching the 3′-
terminal riboadenosine charged with acetylated Ile was de-
tected (Figure 7). Mass peaks corresponding to the 3′-
fragment 3′CCUACC-5′ of tRNA were present in all spec-
tra. Taken together, we conclude that ItaT specifically mod-
ifies charged tRNAIle and the acetyl group is located at the
3′-isoleucyl-adenosine.
To locate further the acetyl group, acetylated Ile-tRNAIle
was digested with RNase A and the 3′-terminal modified
adenosine (m/z 423.3) was subjected to MS-MS analysis
(Supplementary Figure S3). Daughter peaks with m/z 136
and m/z 156, matching intact adenine moiety and acety-
lated isoleucine were observed. We conclude that the acetyl
group is attached to the isoleucine residue.
DISCUSSION
In this work, we establish that ItaT is a type II toxin that
inhibits translation by acetylating Ile-tRNAIle. Though the
itaRT gene pair was identified in the natural E. coli HS
isolate, a virtually identical gene pair is encoded in the
common laboratory strain E. coli BL21(DE3) (locus tags
ECD 00377-ECD 00378). As is the case with many other
TA modules, the functional significance of itaRT to its
hosts, if any, is unknown. It is also not known which sys-
tem may be responsible for reactivation and/or detoxifica-
tion of ItaT-modified aminocylated tRNAIle. Likely candi-
dates are the broad-spectrumdeacetylase CobB or peptidyl-
tRNA hydrolase Pth (11).
ItaT is a novel type II toxin shown to selectively acety-
late specific elongator tRNA. Several other proteins be-
longing to the GNAT family have been shown to be toxic
when overexpressed and/or inhibit translation (17).GNATs
are highly diverse superfamily of proteins performing var-
ious functions in the cell. Substrates for acetylation range
from small molecules to proteins and RNA (41). We per-
formed a phylogenetic analysis of GNAT proteins encoded
in genomes of prokaryotes. 779 distinct acetyltransferases
are encoded next to a gene encoding an identifiable type II
antitoxin, thus forming putative toxin–antitoxin pairs. The
phylogenetic tree shows that all experimentally confirmed
toxin acetyltransferases are monophyletic, forming a com-
pact branch, distant fromother groups of acetyltransferases
(Figure 8A). We named this group the ‘TacT/AtaT/ItaT
group’. TacT/AtaT/ItaT group is very distinct from the rest
of acetyltransferases and covers about 1% of the whole di-
versity of GNATs. These sequences are present in 11 bacte-
rial phyla and are quite abundant in some of them (e.g. in
Proteobacteria, where they are identified in 54 out of 121
families). Most of these genes are encoded in genomes next
to a predicted antitoxin, suggesting that these proteins are
deeply specialized in their roles of toxins in toxin–antitoxin
pairs, presumably as a part of controlled cell death or stress-
resistance systems.
Close examination of the TacT/AtaT/ItaT group identi-
fied five clades potentially corresponding to different speci-
ficities of respective toxins (Figure 8B). One clade in-
cludes AtaT and may comprise acetyltransferases target-
ing methionine moiety on initiator Met-tRNAfMet. TacT
is present in another clade whose members may include
acetyltransferases targeting amino group of various elon-
gator aminoacyl-tRNAs, and thus have relaxed specificity.
Members of the clade that contains ItaT (Figure 8C) may
acetylate elongator Ile-tRNAIle. The remaining two clades
contain no validatedmembers andmay include acetyltrans-
ferases with additional specificities.
There is only one other large GNAT family tree branch
indicated as group X enriched with acetyltransferases en-
coded next to potential antitoxins (Figure 8A). In contrast
to the extended TacT/AtaT/ItaT group that is very dis-
tantly related to other GNATs, group X is relatively small
(297 distinct sequences or∼0.8%of thewhole diversity) and
forms a branch on a periphery of a huge family, containing
the majority of acetyltransferases. GNATs of group X are
part of two-protein systems: one being the acetyltransferase
and another––an Xre-HTH family domain fused to a cupin
domain. The latter combination of domains is often found
as a component of various oxidoreductases, but its specific
function is not known.
The TacT/AtaT/ItaT andX groups together cover about
50% of acetyltransferases that are ever found encoded next
to antitoxin-like transcriptional regulators. The rest, how-
ever, are spread across the tree and do not form coherent
clades.
If the TA modules with acetylating toxins are primar-
ily functioning as selfish and addictive elements, it can be
expected that they will be forced to diversify their tar-
get specificity, as is common, for example, for restriction-
modification systems (42). In this case, one can expect
non-overlapping specificities even for members of the
same clade, perhaps extending to all twenty aminoacyl-
tRNA synthetases. It is worth noting in this respect that
GNAT acetyltransferases MccE acetylate aminoacid moi-
eties of toxic aminoacyl nucleotides and have complex non-
overlapping specificities that depend on the nature of both
the nucleotide and amino acid and may be additionally af-
fected by tailoring modifications (27,43). Closely related
acetyltransferase RimL, responsible for L12 ribosomal pro-
tein acetylation, also contributes to the protection of bac-
teria from toxic aminoacyl nucleotides by acetylating the
aminoacyl moiety (44). Possible evolution of TA systems
from systems of resistance to antibiotics is consistent with
the idea of TA systems functioning as ‘anti-addiction mod-
ules’ (45), useful parasites protecting bacteria from other
parasites.
Investigation of aminoacyl-tRNA acetylating toxins is
still in its infancy. Our study contributed to the charac-
terization of specificity of such toxins towards particular
tRNA species. Further experimental validation of predicted
TAmodules of this kind and investigation of specificities of
their toxins is currently ongoing in our laboratories.
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